AAO: Alcon virtual booth spotlights latest studies, retina product offerings

Video
Conference|AAO

Josh Anderson, head of U.S. retina sales and marketing for Alcon, outlines what attendees will learn including product updates, new technologies, and practice management materials for ophthalmologists and their patients during the COVID-19 pandemic.

Current Time 0:00
Duration 8:09
Loaded: 0%
Stream Type LIVE
Remaining Time 8:09
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected


    Josh Anderson, head of U.S. retina sales and marketing forAlcon, outlines what attendees will learn including product updates, new technologies, and practice management materials for ophthalmologists and their patients during the time of the coronavirus disease 2019 pandemic.

    Retina surgeons, especially, will be interested in the dual-blade vitrectomy probe (Hypervit) as well as a refinement to Grieshaber instrumentation.

    Recent Videos
    Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
    Angiogenesis 2025: The global forecast for AI-driven home OCT
    Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
    Charles Wykoff, MD, PhD, presents on diabetic retinopathy and "the dream of reperfusion" at Floretina ICOOR 2024
    How a gene-agnostic approach opens doors to new therapeutics
    How a gene-agnostic approach opens doors to new therapeutics
    Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
    AAO 2024: Main takeaways from the Zoster Eye Disease study
    Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
    AAO 2024: Elevating patient care through progress in minimally invasive glaucoma surgery
    Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
    AAO 2024: New data illuminate glaucoma care paradigms for surgical interventions
    AAO 2024: Chloroprocaine ophthalmic gel as anesthesia for intravitreal injections
    AAO 2024: Chloroprocaine ophthalmic gel as anesthesia for intravitreal injections
    Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
    AAO 2024: An oral anaesthetic offers relief for both patients and care teams
    AAO 2024: Therapies offering hope for patients diagnosed with TED
    AAO 2024: Therapies offering hope for patients diagnosed with TED
    AAO 2024: Myopic LASIK performed using a novel excimer laser
    AAO 2024: Myopic LASIK performed using a novel excimer laser
    Related Content
    An image of boxing gloves in a ring, hanging over an open flame. ©Image by Jennifer Toomey / MJH Life Sciences using AI

    Up for debate: Clinicians take on hot topics at the Congress on Controversies in Ophthalmology

    Hattie Hayes;Anat Loewenstein, MD;Baruch Kuppermann, MD, PhD
    March 31st 2025
    Article

    This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

    PHOTON Results and Their Relation to DME Patients in Your Practice

    PHOTON Results and Their Relation to DME Patients in Your Practice

    July 25th 2024
    Podcast

    John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

    A blue eye with a large splash of blue liquid coming out of it. Vitreoretinal surgery ILM dye stain concept. Image credit: ©Sergey Nivens – stock.adobe.com

    Internal limiting membrane staining dye ILM-Blue from DORC (Zeiss) receives NMPA approval in China

    Hattie Hayes
    March 27th 2025
    Article

    The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss

    PULSAR Results and Their Relation to nAMD Patients in Your Practice

    PULSAR Results and Their Relation to nAMD Patients in Your Practice

    July 24th 2024
    Podcast

    John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

    A person typing on a computer keyboard as icons representing documents and papers. Research paper publication concept image. Image credit: ©cherdchai – stock.adobe.com

    Nanoscope Therapeutics publishes clinical results of MCO-010 findings for patients with retinitis pigmentosa

    Martin David Harp
    March 26th 2025
    Article

    The synthetic opsin was packaged into an optimised AAV2 gene therapy vector that targets human retinal bipolar cells.

    The Moorfields Eye Hospital NHS Foundation Trust logo courtesy NHS Foundation Trust. Insitro logo courtesy Insitro. Lock and data point assets created with Canva.

    Moorfields Eye Hospital INSIGHT research hub will collaborate with artificial intelligence development company Insitro

    Hattie Hayes
    March 24th 2025
    Article

    The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases

    © 2025 MJH Life Sciences

    All rights reserved.